Sopharma Trading AD (XBUL:SFT) Cyclically Adjusted FCF per Share: €-1.77 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XBUL:SFT Sopharma Trading AD XBUL:SFT
79 GF Score
Price €2.96
GF Value €7.74
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Sopharma Trading AD Cyclically Adjusted FCF per Share?

Sopharma Trading AD XBUL:SFT +2.78% 79 Cyclically Adjusted FCF per Share is €-1.77 as of Mar. 2026. GuruFocus rates XBUL:SFT with a GF Score™ of 79/100 and a GF Value™ of €7.74 (Significantly Undervalued). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Sopharma Trading AD's adjusted free cash flow per share for the three months ended in Mar. 2026 was €0.121. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €-1.77 for the trailing ten years ended in Mar. 2026.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 3.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Sopharma Trading AD was 3.00% per year. The lowest was 3.00% per year. And the median was 3.00% per year.

As of today (2026-08-09), Sopharma Trading AD's current stock price is €2.96. Sopharma Trading AD's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was €-1.77. Sopharma Trading AD's Cyclically Adjusted Price-to-FCF of today is .


Sopharma Trading AD  (XBUL:SFT) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Sopharma Trading AD Cyclically Adjusted FCF per Share Related Terms


Sopharma Trading AD Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Sopharma Trading AD's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sopharma Trading AD Cyclically Adjusted FCF per Share Chart

Sopharma Trading AD Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -1.92 -1.72 -1.66 -1.75

Sopharma Trading AD Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.69 -1.77 -1.78 -1.75 -1.77

XBUL:SFT vs MCK, COR, CAH: Cyclically Adjusted FCF per Share Comparison

For the Medical Distribution subindustry, Sopharma Trading AD's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sopharma Trading AD Cyclically Adjusted Price-to-FCF vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Sopharma Trading AD's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Sopharma Trading AD's Cyclically Adjusted Price-to-FCF falls into.


XBUL:SFT
79GF Score
Sopharma Trading AD XBUL:SFT
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sopharma Trading AD Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Sopharma Trading AD's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.121/330.2130*330.2130
=0.121

Current CPI (Mar. 2026) = 330.2130.

Sopharma Trading AD Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201603 -0.283 238.132 -0.392
201606 -0.436 241.018 -0.597
201612 0.000 241.432 0.000
201703 -0.484 243.801 -0.656
201706 -0.544 244.955 -0.733
201709 -0.306 246.819 -0.409
201712 -0.534 246.524 -0.715
201803 -0.572 249.554 -0.757
201806 -0.688 251.989 -0.902
201809 -1.312 252.439 -1.716
201812 0.002 251.233 0.003
201903 -0.591 254.202 -0.768
201906 -0.999 256.143 -1.288
201909 -0.530 256.759 -0.682
201912 -0.912 256.974 -1.172
202003 -0.773 258.115 -0.989
202006 -0.776 257.797 -0.994
202009 -0.632 260.280 -0.802
202012 -1.210 260.474 -1.534
202103 -0.528 264.877 -0.658
202106 -0.735 271.696 -0.893
202109 -0.833 274.310 -1.003
202112 -0.663 278.802 -0.785
202203 0.018 287.504 0.021
202206 -0.180 296.311 -0.201
202209 -0.061 296.808 -0.068
202212 0.362 296.797 0.403
202303 0.291 301.836 0.318
202306 -0.245 305.109 -0.265
202309 -0.038 307.789 -0.041
202312 0.484 306.746 0.521
202403 -0.192 312.332 -0.203
202406 0.154 314.175 0.162
202409 0.178 315.301 0.186
202412 0.607 315.605 0.635
202503 -0.353 319.799 -0.364
202506 -0.644 322.561 -0.659
202509 0.078 324.800 0.079
202512 0.535 324.054 0.545
202603 0.121 330.213 0.121

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of €-1.77 mean?
Sopharma Trading AD (XBUL:SFT) has a Cyclically Adjusted FCF per Share of €-1.77 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Sopharma Trading AD and its competitors.
Is Sopharma Trading AD's Cyclically Adjusted FCF per Share too high?
Sopharma Trading AD's current Cyclically Adjusted FCF per Share is €-1.77. Overall, Sopharma Trading AD has a GF Score™ of 79/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sopharma Trading AD's Cyclically Adjusted FCF per Share compare to MCK and COR?
Sopharma Trading AD's Cyclically Adjusted FCF per Share of €-1.77 can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Distribution company?
A good Cyclically Adjusted FCF per Share depends on the Medical Distribution industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Sopharma Trading AD and its competitors. Sopharma Trading AD's current Cyclically Adjusted FCF per Share is €-1.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sopharma Trading AD stock overvalued right now?
Based on GuruFocus' analysis, Sopharma Trading AD (XBUL:SFT) is currently considered Significantly Undervalued. The stock's GF Value™ is €7.74, compared to a current price of €2.96 — trading 61.8% below its estimated fair value. The current Cyclically Adjusted FCF per Share is €-1.77. Sopharma Trading AD's overall GF Score™ is 79/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Sopharma Trading AD (XBUL:SFT), the current Cyclically Adjusted FCF per Share is €-1.77 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sopharma Trading AD (XBUL:SFT) Overvalued in 2026?

Based on GuruFocus' analysis, Sopharma Trading AD stock appears to be undervalued. The current stock price of €2.96 is trading 61.8% below its estimated GF Value™ of €7.74. GuruFocus considers Sopharma Trading AD to be Significantly Undervalued.

Key valuation signals for XBUL:SFT:

  • Cyclically Adjusted FCF per Share: €-1.77
  • GF Value™: €7.74 vs. price of €2.96 (61.8% below fair value)
  • GF Score™: 79/100 with 2 warning signs

No single metric tells the full story. See the XBUL:SFT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sopharma Trading AD Business Description

Address Sunrise Street, Lachezar Stanchev, 5 Sopharma, Business Towers, Building A Floor 12, Sofia, BGR, 1756
Sopharma Trading AD is a Bulgaria based company operating in the pharmaceutical sector. The company is engaged in the distribution of pharmaceutical items, including a portfolio of international brands, medicinal products, medical supplies, sanitary and hygienic materials, vitamins, nutritional supplements, cosmetics, medical equipment, and equipment. It also provides turnkey solutions for the construction of medical and hospital establishments. In addition, the group also caters logistics solutions for import, storage, and distribution of goods to end customers.
79GF Score

Get the complete analysis for XBUL:SFT

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.96
Price
€7.74
GF Value